(ARCHIVE) BenevolentAI announces current Board Chair Dr. François Nader to additional role of acting CEO
– UK, London – BenevolentAI (AMS: BAI), a leader in the development of advanced AI that accelerates biopharma discovery, today announced that Dr.…